Showing results (631-640 of 928) with videos related to
Sort By:
Pageof 93
Circulation. Heart Failure|September 17, 2019
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 TrialsAriel Furer, Shmuel Chen, Bjorn Redfors, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 11, 2015
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performanceOluseun Alli, Charanjit S Rihal, Rakesh M Suri, et al.JACC. Cardiovascular Interventions|February 22, 2015
Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial)Samir Kapadia, William J Stewart, William N Anderson, et al.Journal of the American Heart Association|April 16, 2025
Heart Failure With Preserved Ejection Fraction Phenotype Is Associated With Early Symptom Onset in Aortic Stenosis and Residual Symptoms After Transcatheter Aortic Valve ImplantationConstantijn S Venema, Kees H van Bergeijk, Jan A Krikken, et al.JACC. Cardiovascular Interventions|July 9, 2016
Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory StudyPhilippe Généreux, Indulis Kumsars, Joel E Schneider, et al.European Heart Journal|September 11, 2019
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trialTamim M Nazif, Shmuel Chen, Isaac George, et al.Circulation|February 3, 2005
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart AssociationAlexandra J Lansky, Judith S Hochman, Patricia A Ward, et al.Circulation|August 3, 2016
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary InterventionAjay J Kirtane, Darshan Doshi, Martin B Leon, et al.The Journal of Invasive Cardiology|November 8, 2007
Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysisKoichi Sano, Gary S Mintz, Stephane G Carlier, et al.JACC. Cardiovascular Interventions|September 27, 2023
Diagnosis, Classification, and Management Strategies for Mitral Annular Calcification: A Heart Valve Collaboratory Position StatementMayra E Guerrero, Paul Grayburn, Robert L Smith, et al.Pageof 93